FDA Adverse Event
Injury
Summary report: N
INTRACEPT ACCESS INSTRUMENTS
MDR report key: 14740043
·
Received June 18, 2022
Report
- Report Number
- 3006789852-2022-00009
- Event Type
- Injury
- Date Received
- June 18, 2022
- Report Date
- May 18, 2022
- Manufacturer
- RELIEVANT MEDSYSTEMS, INC.
- Product Code
- GXI
- PMA / PMN Number
- K213836
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TX, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
Description of Event or Problem · 0
PATIENT HAD A L5 COMPRESSION FRACTURE 33 DAYS POST-OP. PATIENT WAS SUBSEQUENTLY TREATED WITH AL5 KYPHOPLASTY/ABALOPARATIDE. INTERCEPT TREATMENT OCCURRED ON L4-L5 LEVELS.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1399171 | INTRACEPT ACCESS INSTRUMENTS | PROBE, RADIOFREQUENCY LESION AND ACCESSORIES | GXI | RELIEVANT MEDSYSTEMS, INC. | FG 0060 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 92 YR | Unknown | Required Intervention| S |